SEC Form 4Coverage since Aug 3, 2026
$TLSA insider trading
Over the last 12 months, Tiziana Life Sciences insiders reported 2 buys totaling $986K and no sales across SEC Form 4 filings.
- Bought · 12m
- $986K 2 events
- Sold · 12m
- — 0 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $TLSA · 12Mvia TradingView
Top insiders · 12m
Elrifi IvorChief Executive Officer2× · $986K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Elrifi IvorChief Executive Officer · O | ▲ Buy | 321,423 | $0.99 | $319K | +7.2% | 2 tranches · indirect |
| Aug 3, 2026 | Elrifi IvorChief Executive Officer · O | ▲ Buy | 667,000 | $1 | $667K | +17.5% | indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TLSA feed.